4 unchanged sentences
INDEX TO EXHIBITS
−Removed: Certificate of Change
−Removed: filed with the State of Nevada (incorporated by reference to Exhibit 3.1 of the Form 8-K filed July 22, 2025)
−Removed: Form of Series F Common
−Removed: Warrant issued in May 2025 offering (incorporated by reference to Exhibit 4.1 of the Form 8-K filed May 15, 2025)
−Removed: Form of Pre-Funded Warrant issued in May 2025 offering (incorporated by reference to Exhibit 4.2 of the Form 8-K filed May 15, 2025)
−Removed: Form of Securities Purchase Agreement for May 2025 offering (incorporated by reference to Exhibit 10.1 of the Form 8-K filed May 15, 2025)
−Removed: Placement Agent Agreement dated May 13, 2025 by and between CNS Pharmaceuticals, Inc.
−Removed: and A.G.P./Alliance Global Partners (incorporated by reference to Exhibit 4.1 of the Form 8-K filed May 15, 2025)
+Added: Certificate of Change filed with the State of Nevada (incorporated by reference to Exhibit 3.1 of the Form 8-K filed July 22, 2025)
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.
21 unchanged sentences
Chief Executive Officer and Director
−Removed: August 14, 2025
+Added: November 14, 2025
(principal executive officer)
1 unchanged sentence
Chief Financial Officer
−Removed: August 14, 2025
+Added: November 14, 2025
Christopher Downs
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.